PMP22 and chronic inflammatory demyelinating polyradiculoneuropathy: Studies have also compared the immunological profile of CIDP patients with IgG4 anti-neurofascin 155 (NF155) antibodies (NF155+ CIDP) with patients lacking anti-NF155 antibodies (NF155- CIDP).